Dental implant, bone graft markets seen topping $15B by 2032

By AI, Created 4:30 AM UTC, May 26, 2026, /AGP/ – iData Research projects steady growth in the global dental implant and bone graft substitute markets through 2032, driven by rising tooth loss, implant adoption and expanding regenerative dentistry. Straumann and Geistlich remain among the top competitive forces as digital workflows and biomaterials innovation gain traction.

Why it matters: - The dental implant and bone graft markets are expanding as more patients choose implant-based restorations. - iData Research expects the two markets together to approach $15 billion by 2032, creating room for leading suppliers and newer regenerative technologies. - Growth in digital workflows and biomaterials may also reshape how implant and bone regeneration procedures are planned and delivered.

What happened: - iData Research said the global dental implant and final abutment market was valued at more than $7 billion in 2025 and is projected to exceed $11 billion by 2032. - The firm said that market is expected to grow at a 6.2% compound annual growth rate through 2032. - iData Research said the global dental bone graft substitute and biomaterials market was valued at $2.33 billion in 2025 and is expected to reach nearly $3.8 billion by 2032. - The biomaterials market is projected to grow at a 7.2% compound annual growth rate. - The reports were released by iData Research in Vancouver, British Columbia, Canada, on May 26, 2026.

The details: - Rising tooth loss and stronger patient preference for implant-based restorations are driving both markets. - Zirconia hybrid abutments are gaining traction globally because they combine a ceramic coping with a titanium base. - The abutment design is being used for mechanical reliability and improved visual outcomes, especially in anterior and esthetic zones. - Next-generation resorbable membranes are advancing predictability in guided bone regeneration. - Hybrid membrane designs that combine synthetic polymers with natural collagen are also gaining ground in biomaterials. - North America, Asia-Pacific and Western Europe were the largest regional markets for dental implants and final abutments in 2025. - Those three regions accounted for about three-quarters of total global market value. - Asia-Pacific was also one of the largest markets for dental bone graft substitutes. - Asia-Pacific growth is being supported by a large patient population, broader access to regenerative procedures and more private dental clinics across China, Japan, South Korea and Australia.

Between the lines: - The market data points to a shift from basic implant placement toward digitally enabled, regeneration-focused treatment planning. - Straumann’s scale across implants, abutments, guided surgery and digital workflows gives the company broad exposure to that shift. - Geistlich’s strength in membranes and xenografts suggests bone regeneration remains a key battleground as implant volumes rise. - Smaller regional markets may grow faster than mature markets as dental access improves and clinical awareness expands.

What’s next: - iData Research said the 2026 global dental implant and final abutment report and the 2026 global dental bone graft substitute and other biomaterials report both include market size, unit sales, pricing trends, competitive dynamics and forecasts through 2032. - Straumann Group is expected to remain a major force in implants, supported by Neodent in the value segment. - Geistlich Pharma is expected to remain a leading competitor in biomaterials, alongside Henry Schein and ZimVie after ARCHIMED’s 2025 acquisition. - More adoption of digital workflows and regenerative technologies could keep expanding demand across both markets.

The bottom line: - Dental implants and bone graft biomaterials are on track for solid growth through 2032, with Straumann and Geistlich positioned near the center of the competitive landscape.